Cancer-drug market zooms toward $100B, thanks to costly targeted therapies
06.05.2014 / Fierce Pharma
What's a blockbuster market worth? In the case of cancer treatments, the answer will soon be $100 billion. According to a new study by the IMS Institute for Healthcare Informatics, global oncology spending hit $91 billion last year, and it's growing at a 5% clip annually.